MAYRA ALEJANDRA ESTACIO

Dr. MAYRA ALEJANDRA ESTACIO

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Hematology/Oncology and Stem Cell Therapy
Verified
Journal Article
Open access
DMDiego Medina
Diego Medina
MEMAYRA ALEJANDRA ESTACIO
MAYRA ALEJANDRA ESTACIO
MRMaria Rosales
Maria Rosales
EMEliana Manzi
Eliana Manzi
Background: Haploidentical stem cell transplantation (haplo-SCT) is an option for patients without human leukocyte antigen-matched related or unrelated donor. Post-transplantation cyclophosphamide (PTCy) is an effective method of graft versus host disease (GVHD) prophylaxis and permits the use of T-cell replete grafts in settings were ex vivo manipulation is not feasible. Methods: A retrospective study among patients younger than 18 years, with a history of hematologic malignancies who underwent haplo-SCT between 2012 and 2016. All patients received a preparative regimen of fludarabine, busulfan, and 400 cGy total body irradiation or melphalan. Post-transplant GvHD prophylaxis consisted either of PTCy (50 mg/kg on Days + 3 and + 4) and cyclosporine (CSA) plus mycophenolate (MMF) (15 mg/kg/dose, thrice daily, per os), or minidose methotrexate (MTX; 5 mg/m2 dose) on Days + 5, +7, +10, and + 15. Results: A +total of 52 children were included, whose median age was 9 years (interquartile range, 4.9–14; range, 1.2–17 years), and 63% were males. The most common complications were cytomegalovirus reactivation (57%) and hemorrhagic cystitis (36%). The acute GVHD prophylaxis was PTCy, CSA, and mini-dose MTX in 42 (81%) patients, and 10 (19%) patients received PTCy, CSA, and MMF. The cumulative incidence of acute GvHD II–IV, acute GvHD III–IV, and chronic GvHD were 42%, 8.5%, and 19%, respectively. Grades I–IV acute GvHD occurred in 100% of the patients who received prophylaxis with CSA and MMF, and 62% who received CSA and mini-dose MTX (p = .055). The transplant-related mortality at 100 days was 18%. The 5-year overall and event-free survival were 59% and 57%, respectively. Conclusions: Haplo-SCT with PT/Cy can be an available, safe, and feasible option for children with hematologic malignancies; meanwhile, the use of mini-dose of MTX was associated with lower rates of acute GVHD. However, our results require further support from prospective randomized studies to improve the efficacy of this prophylactic strategy.

1 January 2020 in Hematology, Transfusion and Cell Therapy
Verified
Journal Article
Open access
LDLaura Diaz
Laura Diaz
JRJoaquin Rosales
Joaquin Rosales
FRFernando Rosso
Fernando Rosso
MRMaria Rosales
Maria Rosales
MEMAYRA ALEJANDRA ESTACIO
MAYRA ALEJANDRA ESTACIO
FJFrancisco Javier Jaramillo
Francisco Javier Jaramillo
Cytomegalovirus infection and disease are significant causes of morbidity and mortality among patients with hematopoietic stem cell transplantation. The aim of this study was to assess the frequency of cytomegalovirus infection and characterize the patients who developed the disease. A retrospective cohort study was performed among adult patients, recipients of allogeneic HSTC between 2008 and 2015. Taking into account the institutional protocol of prophylaxis infections in hematopoietic stem cell transplantation, patients received either preemptive therapy or prophylaxis with valganciclovir. Infection was defined as a positive pp65 antigenemia assay or PCR higher than 500copies/mL. Disease was defined as viremia with evidence of end organ damage. Seventy patients were included, the median age was 36 years old (IQR 17-62). A total of 93% of the recipients had a positive serology. The Cytomegalovirus infection occurred in 59% of the patients. Eleven patients developed disease (16%), the most frequent manifestation being colitis, followed by pneumonitis and a single case of retinitis. There were no differences between the preemptive therapy or prophylaxis groups. The mean time of onset of the disease was day 94 post-transplant. Three patients developed disease with a viral load lower than 1000copies/mL. The incidence of cytomegalovirus infection after transplantation at our institution is high. It was found that the disease can occur with any level of viral load and is associated with high mortality.

2 September 2020 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
MOManuela Olaya
Manuela Olaya
AFAlexis Franco
Alexis Franco
MCMauricio Chaparro
Mauricio Chaparro
MEMarcela Estupiñan
Marcela Estupiñan
DADavid Aristizabal
David Aristizabal
DMDiego Medina-Valencia
Diego Medina-Valencia

18 December 2019 in International Journal of Nephrology
Verified
Journal Article
Open access
PDF file
CDCARLOS DURAN
CARLOS DURAN
ARAlejandro Ramírez
Alejandro Ramírez
JPJuan G. Posada
Juan G. Posada
JSJohanna Schweineberg
Johanna Schweineberg
LMLiliana Mesa
Liliana Mesa
VGVictor H. Garcia
Victor H. Garcia
Introduction. In Colombia, the genetic background of the populations was shaped by different levels of admixture between Natives, European, and Africans. Approximately 35.363 patients have diagnosed chronic kidney disease and according to population studies, 10.4% of these patients are Afro-descendant. We aim to assess the frequency of APOL1 variants G1 and G2 in Afro-descendant patients with ESRD treated at la Fundacion Valle del Lili University Hospital in Cali, Colombia. Methods. This is an observational cross-sectional study. Afro-descendant patients with ESRD in waitlist or recipients of kidney transplant were evaluated. Clinical data were collected from the electronic medical records. Genotyping was carried out by amplification of the exon 7 of the APOL1 gene. For the identification of risk genotypes, the bioinformatics tool BLAST was used. Results. We enrolled 102 participants. The frequency of APOL1 risk variants was 67.2%, in which 24.5% (n = 25) were G1 heterozygous and 5.8% (n = 6) were G2 heterozygous and 37% of the patients had high-risk status with two alleles in homozygous (G1/G1 = 21 and G2/G2 = 3) or compound heterozygote (G1/G2 = 14) form.

31 August 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JLJuan David Lopez
Juan David Lopez
MEMAYRA ALEJANDRA ESTACIO
MAYRA ALEJANDRA ESTACIO
NGNatalia Giraldo
Natalia Giraldo
MEManuela Escalante
Manuela Escalante
YRYorlany Rodas
Yorlany Rodas
JGJuan Esteban Gomez
Juan Esteban Gomez
Background: Hypertrophic cardiomyopathy (HCM) is a complex disorder that includes various phenotypes, leading to different manifestations. It also shares different disadvantages typical of rare diseases, including limited recognition, lack of prospective studies assessing treatment, and little or delayed access to advanced treatment options. Reliable data about the prevalence and natural history of cardiomyopathies in South America are lacking. This study summarizes the features and management of patients with HCM in a university hospital in Colombia. Methods: This was an observational retrospective cohort study of patients with HCM between January 2010 and December 2021. Patient data were analyzed from an institutional cardiomyopathy registry. Demographic, paraclinical, and outcome data were collected. Results: A total of 82 patients during the study period were enrolled. Of these, 67.1% were male, and the mean age at diagnosis was 49 years. Approximately 83% were in NYHA functional class I and II, and the most reported symptoms were dyspnea (38%), angina (20%), syncope (15%), and palpitations (11%). In addition, 89% had preserved left ventricular ejection fraction (LVEF) with an asymmetric septal pattern in 65%. Five patients (6%) had alcohol septal ablation and four (5%) had septal myectomy. One patient required heart transplantation during follow-up. Sudden cardiovascular death was observed in 2.6%. The overall mortality during follow-up was 7.3%. Conclusions: HCM is a complex and heterogeneous disorder that presents with significant morbidity and mortality. Our registry provides comprehensive data on disease courses and management in a developing country.

7 March 2025 in Medical Mycology Case Reports
Verified
Journal Article
Open access
MEMAYRA ALEJANDRA ESTACIO
MAYRA ALEJANDRA ESTACIO
RAReino Alberto
Reino Alberto
RJRodelo Joaquin
Rodelo Joaquin
UJUstariz Jose
Ustariz Jose
Fungal peritonitis in peritoneal dialysis (PD) patients is rare but is associated with high morbidity and mortality. Candida species are the most common causative agents, but infections caused by unusual, often “nonpathogenic,” fungi are being increasingly reported. Hyphopichia burtonii is typically associated with food spoilage and has rarely been reported in human infections.